SVP, Investor Relations & Corporate Affairs at Novavax
Ms. Taylor is senior vice president, investor relations and corporate affairs with responsibility for investor relations, public relations, and corporate communications activities at Novavax. She brings more than 25 years of communications and commercial leadership to Novavax. Most recently, she was vice president of global corporate affairs and communications at Autolus Therapeutics plc, where she led all financial, scientific, and corporate communications. Prior to Autolus, Ms. Taylor was senior vice president of global investor relations and corporate affairs at Sucampo. Earlier in her career, she held positions of increasing responsibility at MedImmune LLC, the global biologics arm of AstraZeneca, including head of marketing responsible for the commercialization of the company’s respiratory syncytial virus and influenza franchises, as well as roles at Pfizer, where she served in key brand and consumer marketing roles. She has also worked in public relations and communications roles in agency and nonprofit settings. Ms. Taylor earned a master of business administration degree from Columbia University and a bachelor of arts degree in foreign affairs from University of Virginia.